Delivery Order SPE2DB22D3301-SPE2DB25FY3LD
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,179.45 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a 120 ml medication. The award has an ultimate completion date of April 18, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, with a ceiling value of $6,711.38 and a performance period through May 15, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles, with a ceiling value of $3,422.56 and a performance period ending on May 16, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a ceiling value of $3,154.08 and a performance period through April 11, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The contract is a firm fixed-price delivery order with a ceiling value of $2,908.44 and a period of performance through March 6, 2025. The award is not associated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,516.14, is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a performance period through April 23, 2025. This contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $1,885.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension (120 ml). The contract has a ceiling value of $1,304.07 and a period of performance through May 20, 2025. The contract is not set aside and was awarded on May 19, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, 120 ml, with a potential value of $1,270.30 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a ceiling value of $1,015.19 and a performance period through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...